2015
DOI: 10.1016/j.acvd.2015.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Electrocardiographic detection of left ventricular hypertrophy: Time to forget the Sokolow-Lyon index?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
1

Year Published

2016
2016
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 18 publications
0
4
0
1
Order By: Relevance
“…In addition, a recent investigation by Antikainen et al27 reported that there is no significant increase in the risk of any cardiovascular events associated with LVH diagnosed by SL index. Moreover, Wong et al28 and Courand et al29 once proposed to give up SL criterion as well.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, a recent investigation by Antikainen et al27 reported that there is no significant increase in the risk of any cardiovascular events associated with LVH diagnosed by SL index. Moreover, Wong et al28 and Courand et al29 once proposed to give up SL criterion as well.…”
Section: Discussionmentioning
confidence: 99%
“…LV hypertrophy was defined using the Sokolow Lyon-criteria. 16 17 Fasting blood sugar, lipid profile including high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol, and triglycerides were obtained using a rapid point of care, strip-based test LipidPro by Infopia Ltd, Korea.…”
Section: Methodsmentioning
confidence: 99%
“…Elffers et al [31] showed that discriminative performance of the Sokolow-Lyon voltage criteria is poor (AUC: 0.58) in obese individuals, while Ricciardi et al [62] showed that the Cornel voltage and Cornel product criteria have a more accurate diagnostic performance compared with other hospitalized patients. Courad et al [63] suggested that the R wave in a VL lead should be the first index used to detect LVH of hypertensive patients, and it should replace the Sokolow-Lyon index due to the latter's inadequacies. On the other hand, in the Losartan Intervention For Endpoint (LIFE) study, obese and overweight hypertensive patients had a lower Sokolow-Lyon index in comparison to normal-weight individuals, and a lower prevalence of recognition LVH using a lower Sokolow-Lyon voltage [64].…”
Section: Electrocardiographic Indicatorsmentioning
confidence: 99%